Discover what Percept™ PC Neurostimulator with BrainSense™ Technology has to offer
Based on decades of commitment to deep brain stimulation (DBS), Medtronic is redefining what’s possible with the Percept™ PC device. It enables you to personalize therapy based on objective data and brings forth several leading-edge innovations in a modern, ergonomic, easy-to-use solution that you and your patients want.
Percept™ PC neurostimulator is the only commercially available DBS system with sensing technology1 and ushers in a new era of DBS therapy for Parkinson’s disease, essential tremor, dystonia, and epilepsy.
UNPRECENDENTED INSIGHT INSIDE AND OUTSIDE THE CLINIC
Featuring BrainSense™ technology, designed to capture brain signals (local field potential, or LFP) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.2
Complementing BrainSense™ technology with daily life data capture opportunities
Patients can track up to 4 pre-defined PD events (such as medication adherence, side effects, falls) on their patient programmer, that can be correlated with BrainSense™ technology data by the physician.
THE ONLY 1.5T AND 3T MR CONDITIONAL DBS SYSTEM3
Now you can use MRI eligibility workflow on the clinican programmer to check MRI eligibility, generate an eligibility report and place a patient’s device into the appropriate state for an MRI exam.
New technology and improved longevity
The Percept™ PC neurostimulator is smaller and features a battery that lasts longer.4
Medtronic’s Activa™ PC+S device is not licenced for sale in Canada. As of October 29, 2020 no other sensing-enabled DBS devices have been licencend for sale in Canada.
Signals may not be present or measurable in all patients.
Medtronic DBS systems are MR Conditional, which means they are safe for MRI scans only under certain conditions. If the conditions are not met, the MRI could cause tissue heating, especially at the implanted lead(s) in the brain, which may result in serious and permanent injury or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions. As of October 29, 2020 Medtronic is the only 1.5T and 3T MR conditional DBS system in Canada.
For median energy use in DBS for patients with Parkinson’s disease, with moderate (up to 2 months per year) BrainSense™ technology usage when compared to Activa PC.
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events , If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.ca.